Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nematode muscle GABA receptor, primarily represented by the UNC-49 complex, is a ligand-gated chloride channel essential for inhibitory signaling at the neuromuscular junction (Bamber et al., 1999). In nematodes such as Caenorhabditis elegans and Ascaris suum, this receptor mediates muscle relaxation, which is critical for the undulating movement and locomotion of the organism (Raymond et al., 2000). It is a member of the Cys-loop receptor superfamily and typically functions as a heteromer composed of different subunits (e.g., UNC-49B and UNC-49C) that provide distinct pharmacological properties (Bamber et al., 1999). This receptor is a major target for anthelmintic drugs such as piperazine, which acts as a selective GABA agonist to induce flaccid paralysis in the parasite, allowing it to be expelled from the host's body (Martin, 1997). Understanding the structural and functional differences between nematode UNC-49 receptors and vertebrate GABA_A receptors is crucial for developing selective antiparasitic agents with minimal host toxicity (Accardi et al., 2012).
Agonists bind to the receptor complex at the neuromuscular junction, triggering the opening of an integral chloride-selective pore. The resulting influx of chloride ions hyperpolarizes the muscle cell membrane, inhibiting contraction and leading to flaccid paralysis of the nematode (Martin, 1997; Bamber et al., 1999).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nematode muscle gamma-aminobutyric acid receptor (UNC-49) (UNC-49).